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Abstract
Background: Gastric and colorectal cancers have a major impact on public health, and are the most common
malignant tumors in China. The aim of this research was to study whether polymorphisms of CHCHD3P1-HSP90AB7P,
GRID1, HSPA12A, PRLHR, SBF2, POLD3 and C11orf93-C11orf92 genes are associated with the risk of gastric and colorectal
cancers in the Chinese Han population.
Methods: We genotyped seven single nucleotide polymorphisms (SNPs) from seven genes. We selected 588 patients
with gastric cancer and 449 with colorectal cancer, along with 703 healthy controls. All these SNPs were evaluated
using the χ2 test and genetic model analysis.
Results: The genotype “A/T” of rs12413624 in PRLHR gene was associated with a decreased risk of colorectal
cancer in allele model analysis [odds ratio (OR) = 0.81; 95 % confidence interval (CI) = 0.68–0.97; p = 0.018] and
log-additive model analysis (OR = 0.81; 95 % CI = 0.66–0.98; p = 0.032). The genotype “A/G” of rs1665650 in
HSPA12A gene was associated with a decreased risk of gastric cancer in overdominant model analysis (OR = 0.77;
95 % CI = 0.60–0.99; p = 0.038).
Conclusions: Our results provide evidence that variants of PRLHR gene are a protective factor in colorectal cancer
and variants of HSPA12A gene are a protective factor in gastric cancer in the Chinese Han population.
Background
Gastric and colorectal cancers are two of the most wide-
spread cancers worldwide [1]. Both gastrointestinal ma-
lignancies are leading causes of cancer-related death in
East Asia, Eastern Europe, parts of Central and South
America. With improvements in the standard of living
and changes in lifestyle, food and the environment, the
incidences of gastric and colorectal cancers are con-
stantly increasing in China, where they are now the third
most frequent malignancies [2, 3].
In the present study, the low-risk susceptibility markers
were previously reported in genome-wide association
studies as being related to the risk of digestive system can-
cer: rs10795668 (10p14), rs10788473 (10q23.1), rs1665650
(10q25.3), rs12413624 (10q26.11), rs10500715 (11p15.4),
rs3824999 (11q13.4) and rs3802842 (11q23.1) [4–7].
The prolactin releasing hormone receptor (PRLHR), also
known as G-protein-coupled receptor 10, is the receptor
for prolactin releasing peptide (PrRP). Numerous studies
suggest digestive disease was associated with regulation of
feeding and a pivotal role of PrRP in the homeostatic regu-
lation of feeding and energy balance [8]. Evidence from
our group has shown that central administration of PrRP
decreases feeding and body weight gain in rats and mice,
without causing adverse effects [9]. HSPA12A is a member
of the heat shock protein (HSP) family and a common
molecule within cells that act as a chaperone in conditions
of stress, including carcinogenesis [10]. Overexpression of
HSPA12A might be associated with poor survival in hepa-
tocellular carcinoma. There is a good correlation between
the expression of HSPs and the resistance of cancer cells
to chemotherapy [11]. GRID1 gene encodes glutamate re-
ceptor δ1, a subunit of glutamate receptor channels that
mediate most of the fast excitatory synaptic transmission
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in the central nervous system and play key roles in synap-
tic plasticity [12]. SBF2 gene appears to influence the sort-
ing and degradation of cell surface receptors, such as
epidermal growth factor receptor, with resultant alter-
ations in downstream signaling [4].
The aim of this study was to investigate the relationship
between CHCHD3P1-HSP90AB7P, GRID1, HSPA12A,
PRLHR, SBF2, POLD3, and C11orf93-C11orf92 genes and




The protocol in this study conformed to the principles
of the Declaration of Helsinki and was ratified by the
Ethical Committee of the Second Affiliated Hospital,
Xi’an Jiaotong University School of Medicine, China.
Study population
We recruited 588 patients with gastric cancer and 449
with colorectal cancer between December 2010 and
November 2014 from the Department of General
Surgery, the Second Affiliated Hospital, Xi’an Jiaotong
University School of Medicine. All of the study partici-
pants were from the Chinese Han population living in
the area of Xi’an. Confirmed cases were patients who
were newly diagnosed and histologically confirmed. Ac-
cording to the recruitment and exclusion standards, we
surveyed the patients using a self-designed questionnaire
including demographic factors such as age, gender, and
education, and potential risk factors including smoking,
dietary conditions, alcohol consumption, and family his-
tory of cancer [13]. The controls were 703 healthy indi-
viduals who were selected from June 2011 to October
2014 from the Medical Examination Center, Department
of General Surgery, the Second Affiliated Hospital, Xi’an
Jiaotong University School of Medicine. The controls were
all Chinese Han living in Xi’an city and surrounding area.
We excluded patients with chronic diseases of the kidneys,
heart, liver and brain. All participants gave signed in-
formed consent prior to participation in the study.
Genotyping
We genotyped seven single nucleotide polymorphisms
(SNPs) with minor allele frequency (MAF) > 5 % in seven
genes in the HapMap Asian population. Genomic DNA
was stored at −20 °C and was extracted from whole blood
by the phenol–chloroform extraction method. Using an ex-
traction kit (GoldMag, China), we isolated DNA from the
samples. DNA concentration was measured by spectrom-
etry (DU530 UV/VIS spectrophotometer; Beckman Instru-
ments, Fullerton, CA, USA). We designed the Multiplexed
SNP Mass EXTEND assay using Sequenom MassARRAY
Assay Design version 4.0 software [14].
Statistical analysis
The genotype frequencies of each SNP in the control
subjects were checked using the Hardy–Weinberg equilib-
rium (HWE). Power analysis was carried out using the
online calculator at http://sampsize.sourceforge.net/iface/
s3.html. Data analysis was performed using SPSS version
16.0 statistical package (SPSS, Chicago, IL, USA) and
Microsoft Excel. P < 0.05 was considered to represent
statistical significance. Differences in the distribution
were analyzed using logistic regression. The genotype
frequencies of cases and controls were calculated using
a χ2 test [15, 16]. Odds ratios (ORs) and 95 % confidence
intervals (CIs) were tested using unconditional logistic re-
gression analysis with adjustment for age and gender [17].
The allele, overdominant and log-additive models were
applied using PLINK software (http://pngu.mgh.harvar-
d.edu/purcell/plink/) to assess the association of SNPs
with the risk of gastric and colorectal cancers.
Results
The 588 gastric cancer cases comprised 392 men and 196
women with a mean age of 58.12 ± 11.66 years. The 449
colorectal cancer cases comprised 260 men and 189
women with a mean age of 59.09 ± 11.78 years. The 703
healthy controls comprised 396 men and 307 women with
a mean age of 48.57 ± 9.43 years. We found no differences
between gender and age distribution. The characteristics
of the patients and controls are shown in Table 1. The
primers of the seven selected SNPs are shown in Table 2,
which were designed by Sequenom MassARRAY Assay
Design 4.0 Software [14]. Seven SNPs in seven genes were
analyzed in this study. SNP ID, gene, HWE test results,
minor/major alleles, and MAF of cases and controls of all
the SNPs are shown in Table 3. The minor allele of each
SNP, a risk factor, was compared with the wild-type allele.
Further model association analyses used logistic
tests including allele model, overdominant model and
log-additive model (Table 4). The genotype “A/T” of
rs12413624 is associated with a decreased risk of
colorectal cancer by allele model analysis (OR = 0.81;
95 % CI = 0.68–0.97; p = 0.018) and log-additive model
Table 1 Demographic characteristics of patients with gastric
and colorectal cancers, and controls
Group (N) Age (years) Gender
(male/female)
P valuea P valueb
Healthy controls
(N = 703)
48.57 ± 9.43 396/307 – –
Gastric cancer
cases (N = 588)
58.12 ± 11.66 392/196 0.21 0.54
Colorectal cancer
cases (N = 449)
59.09 ± 11.78 260/189 0.32 0.25
aP value is based on the age versus healthy controls in the study
bP value is based on the gender versus healthy controls in the study
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analysis (OR = 0.81; 95 % CI = 0.66–0.98; p = 0.032).
The genotype “A/G” of rs1665650 was associated with
a decreased risk of gastric cancer risk by overdomi-
nant model analysis (OR = 0.77; 95 % CI = 0.60–0.99;
p = 0.038).
Discussion
Gastric and colorectal cancers are the most frequent ma-
lignancies diagnosed worldwide and the most common
cause of cancer mortality in China [18]. Environmental
components are risk factors for the development of gas-
tric and colorectal cancers, such as Helicobacter Pylori
infection, salted food intake, changed lifestyle and smok-
ing, and their mortality rates are continually increasing
in China [19, 20].
In this study, we showed that the PRLHR gene, which
is mapped to chromosome 10q26.11, contained an SNP
(genotype “A/T” of rs12413624) associated with a in-
creased risk of colorectal cancer. PRLHR is the receptor
for PrRP (also known as G-protein-coupled receptor 10)
and has pivotal functions in press hormone release and
feeding behavior [21]. PrRP, a hormone, may be secreted
from peripheral tissues (pancreas, placenta, adrenal)
upon the anterior pituitary, or may be secreted from
hypophysiotropic neurons by an indirect pivotal mech-
anism [22]. It was also reported that PRLHR, as well as
involvement in the physiological responses to central
dministration of PrRP, may play roles in other pro-
cesses, such as feeding behavior, pathogenesis of uterine
fibroids, energy expenditure, obesity and the pivotal
control of blood pressure [8, 23, 24]. According to pre-
vious reports, rs12413624 is associated with pancreatic
ductal adenocarcinoma risk in individuals of European
descent but not in Japanese and Chinese populations
[25]. We discovered the relationship between rs12413624
in the PRLHR gene and colorectal cancer in the allele and
the log-additive models. However, we did not find any cor-
relation between the PRLHR gene and gastric cancer. It is
necessary to study the biological functions of the PRLHR
gene in further research.
We genotyped “A/G” of rs1665650 in HSPA12A gene,
which is mapped to chromosome 10q25.3, and associ-
ated with a decreased risk of gastric cancer. HSPA12A,
heat shock 70-kDa protein 12A, is a novel and atypical
member of the HSP70 family in animals. Its effects are
diverse and include involvement in the development of
atherosclerotic lesions in mice [26]. Cancer cells experi-
ence high levels of proteotoxic stress and rely upon
stress response pathways for survival and proliferation,
thereby becoming dependent on proteins such as
stress-inducible HSPs. It is reported that overexpres-
sion of HSPA12A in hepatocellular carcinoma tissues is
Table 2 Primers used for this study
SNP ID 1st – PCR primer sequences 2nd – PCR primer sequences UEP sequences
rs10795668 ACGTTGGATGAATACTTGTACCTTGGTGGG ACGTTGGATGTCATCTATGAGCAGCAGCAG gcGAAAGAGAAAAAGTTAGATTCTTA
rs10788473 ACGTTGGATGCAGGAAGTGACAGCTATCTC ACGTTGGATGGGCTTCATTGGGAGCTAGTG ggggaTCCAAGCTACGGCTCACCTGG
rs1665650 ACGTTGGATGCCAACTGAGGATGATTTGAC ACGTTGGATGGGTTGTTTGGCTACTCAAAG ctccAAATGTCTATCGCCTTTAC
rs12413624 ACGTTGGATGGCTAGGTGTGGCACTGTTTG ACGTTGGATGTTATGCAACTGGTCCTGGTC tgggtTGGTCCTGGTCAGATGTTAT
rs10500715 ACGTTGGATGAGGCTTGAGATTTGGAAGGC ACGTTGGATGCCATCTTTAGATCTTCTCTC cttTTTAGATCTTCTCTCAGTCTA
rs3824999 ACGTTGGATGCTAAATCCCCTTTGCTGGAC ACGTTGGATGGATCAGAGAACTACAAGCAC TTCTCCATTGGTTCTCTAA
rs3802842 ACGTTGGATGCATCGTTTTGTTAGGAAGAC ACGTTGGATGGGCCCCTAAAATGAGGTGAA aagGAGGTGAATTTCTGGGA
PCR polymerase chain reaction, UEP unextended mini-sequencing primer
Table 3 Basic information of candidate SNPs in this study







Gastric cancer Colorectal cancer
rs10795668 CHCHD3P1–HSP90AB7P 0.1739 A/G 0.384 0.369 0.348
rs10788473 GRID1 0.7497 T/C 0.383 0.391 0.378
rs1665650 HSPA12A 1 A/G 0.312 0.316 0.33
rs12413624 PRLHR 0.3968 A/T 0.431 0.405 0.381
rs10500715 SBF2 0.9056 G/T 0.198 0.212 0.205
rs3824999 POLD3 0.7421 C/A 0.361 0.346 0.391
rs3802842 C11orf92–C11orf93 0.3986 C/A 0.435 0.441 0.478
A/B stands for minor/major alleles on the control sample frequencies
SNPs are excluded at 5 % HWE P level
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significantly related to poor survival [11]. During car-
cinogenesis, expression of HSPs is altered in many
tumor types. Increased levels of HSPA are related to
malignancy, metastasis, poor prognosis, and resistance
to therapeutic strategies, including chemotherapy or
radiation in glioblastoma, and breast, bladder, endomet-
rial and cervical carcinomas [27–29]. It is also reported
that the associations between rs1665650, rs3824999
and colorectal cancer are not strongly modified by
gender, alcohol, smoking, aspirin, and various dietary
factors [30]. Our results showed that rs1665650 in
HSPA12A gene is correlated with gastric cancer risk,
and we did not find a significant association with the
risk of colorectal cancer. Further research should use a
larger number of samples and focus on understanding
the mechanisms by which HSPA12A gene influences
pathogenesis and progression.
The rs10795668 in CHCHD3P1-HSP90AB7P gene is
associated with the risk of colorectal cancer in Poland,
Estonia, Lithuania and Latvia [31]. Somatic exonuclease
domain mutations in POLE gene have been identified in
colorectal and endometrial cancer patients, and show an
association with hypermutability and microsatellite sta-
bility [32]. In both population that included cases of
European descent and in a combined analysis with cases
from China, SNPs in the SBF2 gene were associated with
survival time among patients with pancreatic adenocar-
cinoma [7]. However, we did not find that SNPs and
genes were associated with gastric or colorectal cancers
in our study.
There were several limitations to our study. First, all the
samples were from the Chinese Han population living in
Xi’an city or its surrounding area and from the same
hospital. There were a substantial number of confounding
factors that may have caused type I errors (false-positive
results) in our association study. Second, we also performed
Bonferroni correction of the 21 tests and found no signifi-
cant results. However, the main weakness of Bonferroni
correction is that the interpretation of a finding depends on
the number of other tests performed. True important dif-
ferences may be deemed nonsignificant since the likelihood
of type II errors also increased [33]. Finally, our samples
included 1037 cases (588 gastric cancer and 449 colorectal
cancer) and 703 healthy controls and we performed a
power analysis that showed that the power of seven SNPs
was < 0.75. The sample size was not large enough for asso-
ciation studies and a larger sample size is required to con-
firm our findings.
Table 4 Association of SNPs with risk of gastric and colorectal cancers based on logistic tests adjusted by gender and age
SNP ID Model Genotype Gastric cancer Colorectal cancer
OR (95 % CI) P value OR (95 % CI) P value
rs10795668 Allele model A/G 0.94 (0.80–1.10) 0.419 0.86 (0.70–1.02) 0.082
Overdominant model A/G 0.97 (0.76–1.23) 0.78 0.89 (0.68–1.17) 0.41
Log - additive model – 0.95 (0.80–1.13) 0.56 0.86 (0.71–1.04) 0.12
rs10788473 Allele model T/C 1.04 (0.88–1.22) 0.655 0.98 (0.82–1.17) 0.817
Overdominant model T/C 0.86 (0.68–1.10) 0.24 1.06 (0.81–1.39) 0.66
Log - additive model – 1.04 (0.88–1.24) 0.63 0.91 (0.75–1.11) 0.34
rs1665650 Allele model A/G 1.02 (0.86–1.21) 0.85 1.09 (0.91–1.30) 0.363
Overdominant model A/G 0.77 (0.60–0.99) 0.038* 1.04 (0.80–1.36) 0.78
Log - additive model – 1 (0.83–1.20) 0.99 1.16 (0.95–1.42) 0.15
rs12413624 Allele model A/T 0.9 (0.77–1.05) 0.191 0.81 (0.68–0.96) 0.018*
Overdominant model A/T 0.91 (0.72–1.17) 0.47 0.9 (0.69–1.18) 0.44
Log - additive model – 0.93 (0.77–1.11) 0.39 0.81 (0.66–0.98) 0.032*
rs10500715 Allele model G/T 1.09 (0.90–1.32) 0.387 1.04 (0.85–1.28) 0.699
Overdominant model G/T 1.1 (0.85–1.42) 0.48 0.94 (0.71–1.26) 0.69
Log - additive model – 1.07 (0.87–1.32) 0.53 1.05 (0.83–1.32) 0.7
rs3824999 Allele model C/A 0.94 (0.80–1.10) 0.432 1.14 (0.95–1.35) 0.151
Overdominant model C/A 0.81 (0.64–1.04) 0.1 0.98 (0.75–1.28) 0.9
Log - additive model – 0.92 (0.77–1.10) 0.37 1.13 (0.93–1.37) 0.21
rs3802842 Allele model C/A 1.02 (0.88–1.20) 0.774 1.19 (1.00–1.40) 0.541
Overdominant model C/A 0.99 (0.77–1.26) 0.91 1.09 (0.84–1.42) 0.52
Log - additive model – 0.96 (0.81–1.14) 0.68 1.14 (0.94–1.37) 0.18
*p < 0.05, statistical significance
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Conclusions
This study shows that PRLHR gene is a protective factor
in colorectal cancer and HSPA12A gene is a protective
factor in gastric cancer. We demonstrated a relationship
between polymorphisms of PRLHR and HSPA12A gene
and the risk of gastric and colorectal cancers in the
Chinese Han population.
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